Skip to main content


Ovarian Cancer

Featured

Quiz
True or False: Targeted BRCA or multiple gene screening is cost-effective to prevent breast and ovarian cancer.
News
Results from a single-center study show payers incur the bulk of monthly PARP inhibitor cost for ovarian cancer.
News
Targeted BRCA or multiple gene screening is cost-effective for preventing breast and ovarian cancer, according to a…
Quiz
True or False: Rucaparib improves PFS compared with chemotherapy in patients with relapsed BRCA-mutated ovarian cancer.
News
PARP inhibitor therapy costs account for over 90% of patients’ total out-of-pocket drug spending. However, payers are…
Back to Top